CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-09 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-05-08 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-04-27 | Graff Jeremy R. Director | Returned to the company · Series B Warrants (right to buy) | −2,049 | 0 | ||
| 2025-04-27 | Graff Jeremy R. Director | Grant or award · Series B Warrants (right to buy) | +2,049 | 2,049 | ||
| 2024-12-19 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +47,697 | 47,697 | ||
| 2024-06-12 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award | +2,049 | 4,549 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award · Series A Warrants (right to buy) | +2,049 | 2,049 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award · Series B Warrants (right to buy) | +2,049 | 2,049 | ||
| 2023-09-13 | Graff Jeremy R. Director | Purchase | +2,500 | $0.95 | $2K | 2,500 |
| 2023-06-15 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-05-01 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 |
Page 1 of 1 · 12 trades